Skip to main content

Advertisement

SpringerLink
Log in

Current treatments in neurology: Stroke

  • ENS TEACHING REVIEW
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

There have been major advances in stroke treatment based on robust evidence from large clinical trials. This review covers both acute treatment and secondary prevention. Thrombolysis is now established as a therapy for ischaemic stroke presenting within 3 hours, and the possibility of extending the time window and refining the selection of suitable patients, is being addressed in further trials. Anticoagulants are of proven benefit in cardioembolic stroke, and particularly atrial fibrillation. For prevention of other stroke subtypes antiplatelet agents appear to have a better risk–benefit ratio. Evidence for the use of dual antiplatelet therapy, including the recent MATCH study, are discussed. Carotid endarterectomy is of proven benefit in patients with > 70% symptomatic stenosis. Recent analysis has emphasised the importance of operating as soon after symptom onset as possible. Operating on asymptomatic carotid stenosis remains controversial; even after the recent Asymptomatic Carotid Surgery Trial which showed that by operating on 32 people one disabling stroke or death could be prevented over a 5 years period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Markus HS (2004) Cerebral perfusion and stroke. J Neurol Neurosurg Psychiatry 75:353–361

    Google Scholar 

  2. Stroke Unit Trialists’ Collaboration (2002) Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 1:CD000197

    Google Scholar 

  3. Jarman B, Aylin P, Bottle A (2004) Acute stroke units and early CT scans are linked to lower in-hospital mortality rates. BMJ 328:369

    Google Scholar 

  4. Lincoln NB, Husbands S, Trescoli C, et al. (2000) Five year follow up of a randomised controlled trial of a stroke rehabilitation unit. BMJ 320:549

    Google Scholar 

  5. NINDS rt_PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 333:1581–1587

    Google Scholar 

  6. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E (2003) Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 3:CD000213

    Google Scholar 

  7. Hacke W, Donnan G, Fieschi C, et al. (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768–774

    Article  PubMed  Google Scholar 

  8. SITS-MOST registration details available on<www.acutestroke.org>

  9. Baron JC (1999) Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovas Dis 9:193–201

    Google Scholar 

  10. Lapchak PA, Araujo DM (2003) Therapeutic Potential of Platelet Glycoprotein IIb/IIIa Receptor Antagonists in the Management of Ischemic Stroke. Am J Cardiovasc Drugs 3:87–94

    Google Scholar 

  11. Muir KW, Lees KR, Ford I, Davis S; Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators (2004) Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 363:439–445

    Google Scholar 

  12. Pound P, Ebrahim S, Sandercock P, Bracken MB, Roberts I (2004) Reviewing Animal Trials Systematically (RATS) Group.Where is the evidence that animal research benefits humans? BMJ 328:514–517

    Google Scholar 

  13. International Stroke Trialists Collaborative Group (1997) The International Stroke Trial (IST); a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients. Lancet 349:1569–1581

    Article  PubMed  Google Scholar 

  14. CAST (Chinese Acute Stroke Trial) Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke. Lancet 349:1641–1649

    Google Scholar 

  15. Mendelow AD; Investigators and the Steering Committee (2003) The International Surgical Trial in Intracerebral Haemorrhage (ISTICH). Acta Neurochir Suppl (Wien) 86:441–443

    Google Scholar 

  16. Lindsberg PJ, Roine RO (2004) Hyperglycaemia in acute stroke. Stroke 35:363–364

    Google Scholar 

  17. Parsons MW, Barber PA, Desmond PM, et al. (2002) Acute hyperglycaemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 52:20–28

    Google Scholar 

  18. Johnston SC, Gress DR, Browner WS, Sidney S (2000) Short-term prognosis after emergency department diagnosis of TIA. JAMA 284:2901–2906

    Google Scholar 

  19. Lovett JK, Dennis MS, Sandercock PA, et al. (2003) Very early risk of stroke after a first transient ischaemic attack. Stroke 34:e138–e140

    Google Scholar 

  20. Coull AJ, Lovett JK, Rothwell PM; Oxford Vascular Study (2004) Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 328:326–328

    Google Scholar 

  21. Antithrombotic Trialists’Collaboration (2002)Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71–86

    Article  PubMed  Google Scholar 

  22. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group (1997) A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 42:857–865

    Google Scholar 

  23. Mohr JP, Thompson JL, Lazar RM, et al.; Warfarin-Aspirin Recurrent Stroke Study Group (2001) A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345:1444–1451

    Article  CAS  PubMed  Google Scholar 

  24. Diener HC, Cunha L, Forbes C, et al. (1996) European Stroke Prevention Study. 2.Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143:1–13

    Article  CAS  PubMed  Google Scholar 

  25. CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339

    Article  PubMed  Google Scholar 

  26. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494–502

    Google Scholar 

  27. Steinhubl SR, Berger PB,Mann JT, et al.; CREDO Investigators (2002) Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288:2411–2420

    Google Scholar 

  28. Diener HC, Bogousslavsky J, Brass LM, et al. (2004) MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364:331–337

    Google Scholar 

  29. Hart RG, Benavente O, McBride R, Pearce LA (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131:492–501

    Google Scholar 

  30. EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342:1255–1262

    Google Scholar 

  31. Hankey GJ, Klijn CJM, Eikelboom JW (2004) Ximelagatran or warfarin for stroke prevention in patients with atrial fibrillation? Stroke 35:389–391

    Google Scholar 

  32. Randomised trial of a perindoprilbased blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (2001) Lancet 358:1033–1041

    Article  PubMed  Google Scholar 

  33. Yusuf S, Sleight P, Pogue J, et al. (2000) Effects of an angiotensin-convertingenzyme inhibitor, ramapril, on cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145–153

    Google Scholar 

  34. Dahlof B, Devereux RB, Kjeldsen SE, et al. (2000) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995–1003

    Google Scholar 

  35. Amarenco P, Lavallee P, Touboul PJ (2004) Statins and stroke prevention. Cerebrovasc Dis 17(Suppl 1):81–88

    Google Scholar 

  36. Collins R, Armitage J, Parish S, Sleight P, Peto R; Heart Protection Study Collaborative Group (2003) MRC/BHF Heart Protection Study of cholesterollowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016

    Article  PubMed  Google Scholar 

  37. European Carotid Surgery Trialists’ Collaborative Group (1998) Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results in the MRC European Carotid Surgery Trial (ECST). Lancet 351:1379–1387

    PubMed  Google Scholar 

  38. North American Symptomatic Carotid Endarterectomy Trial Collaborators (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 325:445–453

    PubMed  Google Scholar 

  39. Barnett HJM, Taylor DW, Eliasziw M, et al. for the North American Symptomatic Carotid Endarterectomy Trial Collaborators (1998) Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 339:1415–1425

    Article  CAS  PubMed  Google Scholar 

  40. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists Collaboration (2004) Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363:915–924

    Article  CAS  PubMed  Google Scholar 

  41. CAVATAS Investigators: Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial (2001) Lancet 357:1729–1737

    Article  PubMed  Google Scholar 

  42. Asymptomatic Carotid Atherosclerosis Study Group (1995) Carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis. JAMA 273:1421–1428

    PubMed  Google Scholar 

  43. Halliday A, Mansfield A, Marro J, et al. (2004) MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363:1491–1502

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Neuroscience, St George’s Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK

    Hugh S. Markus

Authors
  1. Hugh S. Markus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hugh S. Markus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Markus, H.S. Current treatments in neurology: Stroke. J Neurol 252, 260–267 (2005). https://doi.org/10.1007/s00415-005-0736-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0736-9

Key words

Search

Navigation